Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Culig

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
European Urology|October 31, 2001
Molecular biology of the androgen receptor: from molecular understanding to the clinicI E Eder, Z Culig, T Putz, et al.
Urologia Internationalis|October 12, 2000
Antagonist/agonist balance of the nonsteroidal antiandrogen bicalutamide (Casodex) in a new prostate cancer modelA Hobisch, J Hoffmann, L Lambrinidis, et al.
The Prostate|January 1, 1993
DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reactionZ Culig, H Klocker, J Eberle, et al.
The Prostate|August 4, 1998
Expression of Lewis carbohydrate antigens in metastatic lesions from human prostatic carcinomaZ Culig, A Hittmair, A Hobisch, et al.
The Prostate. Supplement|August 5, 1998
Presence of chromogranins and regulation of their synthesis and processing in a neuroendocrine prostate tumor cell lineR Ischia, Z Culig, U Eder, et al.
International Journal of Oncology|July 31, 1998
Characterisation of a collecting duct carcinoma by cytogenetic analysis and comparative genomic hybridisationI Verdorfer, Z Culig, A Hobisch, et al.
Drugs & Aging|January 1, 1997
Androgen receptor gene mutations in prostate cancer. Implications for disease progression and therapyZ Culig, A Hobisch, A Hittmair, et al.
The Prostate|April 16, 1998
Expression, structure, and function of androgen receptor in advanced prostatic carcinomaZ Culig, A Hobisch, A Hittmair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotypeA Hobisch, R Ramoner, D Fuchs, et al.
World Journal of Urology|January 1, 1995
Activation of the androgen receptor by polypeptide growth factors and cellular regulatorsZ Culig, A Hobisch, M V Cronauer, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
European Urology|October 31, 2001
Molecular biology of the androgen receptor: from molecular understanding to the clinicI E Eder, Z Culig, T Putz, et al.
Urologia Internationalis|October 12, 2000
Antagonist/agonist balance of the nonsteroidal antiandrogen bicalutamide (Casodex) in a new prostate cancer modelA Hobisch, J Hoffmann, L Lambrinidis, et al.
The Prostate|January 1, 1993
DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reactionZ Culig, H Klocker, J Eberle, et al.
The Prostate|August 4, 1998
Expression of Lewis carbohydrate antigens in metastatic lesions from human prostatic carcinomaZ Culig, A Hittmair, A Hobisch, et al.
The Prostate. Supplement|August 5, 1998
Presence of chromogranins and regulation of their synthesis and processing in a neuroendocrine prostate tumor cell lineR Ischia, Z Culig, U Eder, et al.
International Journal of Oncology|July 31, 1998
Characterisation of a collecting duct carcinoma by cytogenetic analysis and comparative genomic hybridisationI Verdorfer, Z Culig, A Hobisch, et al.
Drugs & Aging|January 1, 1997
Androgen receptor gene mutations in prostate cancer. Implications for disease progression and therapyZ Culig, A Hobisch, A Hittmair, et al.
The Prostate|April 16, 1998
Expression, structure, and function of androgen receptor in advanced prostatic carcinomaZ Culig, A Hobisch, A Hittmair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotypeA Hobisch, R Ramoner, D Fuchs, et al.
World Journal of Urology|January 1, 1995
Activation of the androgen receptor by polypeptide growth factors and cellular regulatorsZ Culig, A Hobisch, M V Cronauer, et al.
Pageof 6